Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 ...Middle East

SUZHOU, China, June 1, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that clinical...

Hence then, the article about transcenta releases phase i clinical data of tst001 in combination with capox as the first line treatment of advanced and metastatic g gej cancer at asco 2022 was published today ( Thursday 02/06/2022 - 03:28 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Transcenta Releases Phase I Clinical Data of TST001 in Combination with CAPOX as the First Line Treatment of Advanced and Metastatic G/GEJ Cancer at ASCO 2022 )

Also on site :

• ‘Trump 2028’: President poses as decorated general and threatens to run again in bizarre series of AI posts
• White House’s push to delay hemp product ban could have big benefit to Susie Wiles’ son-in-law: reports
• ‘She had a future and it was taken’: Family and friends release balloons for 14-year-old Zah’nia Barr, shot and killed in Rochester